Pharma Companies Turn to FDA for Social Media Guidance

The FDA’s “seeming lack of participation” regarding the development of social media guidelines has frustrated many in the affected communities. But pharma specialist Mark Senak says the recent influx of public comment submissions by pharma companies means the agency will soon face the challenge of “providing guidance that is broad enough to cover change.”



Related Posts

  1. Leaked Documents Shed Light on More Than War in Afghanistan

    Among obvious concerns, WikiLeaks’ release of more than 90,000 secret U.S. military documents relating to the war in Afghanistan will put the Obama administration’s “21st century statecraft” strategy to the test. The digital specialists from Public Affairs 2.0 take a look at what happens “when crisis communications takes on new meaning.”

  2. What Women Really Want: New Insight About the Female Consumer

    Marketers may be surprised to learn which sources of information women find essential to their shopping. The team from Word of Mouth looks inside a Fleishman-Hillard study and discovers new insight into “what women are thinking.”

  3. Pharma Meet Facebook, Facebook Meet Pharma

    Pharma specialist Mark Senak talks about the pharmaceutical industry’s slow adoption of Facebook and explains why medical product manufacturers should take advantage of this “extremely important referral source.”

Subscribe Subscribe to RSS

Learn More: Digital & Social Media · Healthcare · Public Affairs

Opinions

 

Archives